IE
RVMD icon

Israel Englander’s Revolution Medicines RVMD Stock Holding History

Israel Englander’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40.5M Sell
216,208
-161,124
-43% -$23.5M 0.01% 1031
2026
Q1 		$36.7M Sell
377,332
-422,786
-53% -$42.7M 0.02% 1069
2025
Q4 		$63.7M Buy
800,118
+371,809
+87% +$24.4M 0.03% 647
2025
Q3 		$20M Sell
428,309
-952,532
-69% -$37.3M 0.01% 1665
2025
Q2 		$50.8M Buy
1,380,841
+1,224,488
+783% +$47M 0.02% 808
2025
Q1 		$5.53M Buy
+156,353
New +$6.35M ﹤0.01% 2754
2024
Q2 		– Sell
-7,661
Closed -$286K – 6446
2024
Q1 		$247K Buy
+7,661
New +$227K ﹤0.01% 5257
2023
Q4 		– Sell
-247,816
Closed -$5.95M – 6469
2023
Q3 		$6.86M Sell
247,816
-126,274
-34% -$3.75M ﹤0.01% 2413
2023
Q2 		$10M Sell
374,090
-178,961
-32% -$4.39M ﹤0.01% 2024
2023
Q1 		$12M Buy
553,051
+435,447
+370% +$10.7M 0.01% 1782
2022
Q4 		$2.8M Sell
117,604
-392,921
-77% -$8.35M ﹤0.01% 3275
2022
Q3 		$10.1M Buy
510,525
+255,082
+100% +$5.61M 0.01% 2125
2022
Q2 		$4.98M Buy
255,443
+231,670
+975% +$4.51M ﹤0.01% 2816
2022
Q1 		$606K Sell
23,773
-13,376
-36% -$291K ﹤0.01% 4970
2021
Q4 		$935K Sell
37,149
-149,822
-80% -$4.22M ﹤0.01% 4469
2021
Q3 		$5.14M Buy
186,971
+145,151
+347% +$4.22M ﹤0.01% 2827
2021
Q2 		$1.33M Buy
41,820
+23,525
+129% +$821K ﹤0.01% 4400
2021
Q1 		$839K Sell
18,295
-168,134
-90% -$7.54M ﹤0.01% 4381
2020
Q4 		$7.38M Buy
+186,429
New +$7.37M 0.01% 2080
2020
Q3 		– Sell
-8,827
Closed -$279K – 4766
2020
Q2 		$279K Sell
8,827
-101,462
-92% -$3.19M ﹤0.01% 3699
2020
Q1 		$2.42M Buy
+110,289
New +$3.05M 0.01% 1875

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Israel Englander's RVMD Position: Q2 2026 in Review

Israel Englander reduced its Revolution Medicines (RVMD) stake by 43% in Q2 2026, selling an estimated $23.5M and leaving 216,208 shares worth $40.5M. The position accounts for 0.01% of the portfolio, ranked #1031.

Israel Englander first reported a position in RVMD in Q1 2020 and has held it in 21 quarters since. The position peaked at $63.7M in Q4 2025. 688 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Israel Englander held 216,208 shares of Revolution Medicines worth $40.5M as of Q2 2026.
  • Israel Englander sold 161,124 Revolution Medicines shares in Q2 2026, an estimated $23.5M.
  • Revolution Medicines made up 0.01% of Israel Englander's portfolio in Q2 2026, its #1031 holding.
  • Israel Englander first reported a position in Revolution Medicines in Q1 2020 and has held it in 21 quarters since.
  • Israel Englander's Revolution Medicines position peaked at $63.7M in Q4 2025.
  • 688 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.